BROADWOOD CAPITAL INC — Form 4 insider transactions
BROADWOOD CAPITAL INC — Full 13F portfolio →
Buys and sells reported on SEC Form 4 — filed within two business days of each trade when a filer's ownership in a stock crosses 10%. This is the fastest public window into what the manager is doing.
| Transaction date | Activity | Security | Shares | Price | Total | Filing |
|---|---|---|---|---|---|---|
| 2026-04-27 | Buy | Insight Molecular Diagnostics Inc. | — | — | — | SEC filing |
| 2026-04-27 | Buy | Insight Molecular Diagnostics Inc. | 250,923 | $3.64 | $913,134 | SEC filing |
| 2026-04-24 | Buy | Insight Molecular Diagnostics Inc. | — | — | — | SEC filing |
| 2026-04-24 | Buy | Insight Molecular Diagnostics Inc. | 38,880 | $3.53 | $137,083 | SEC filing |
| 2026-04-23 | Buy | Insight Molecular Diagnostics Inc. | — | — | — | SEC filing |
| 2026-04-23 | Buy | Insight Molecular Diagnostics Inc. | 280,381 | $3.50 | $982,034 | SEC filing |
| 2026-04-20 | Buy | Insight Molecular Diagnostics Inc. | — | — | — | SEC filing |
| 2026-04-20 | Buy | Insight Molecular Diagnostics Inc. | 40,690 | $3.88 | $157,967 | SEC filing |
| 2026-04-17 | Buy | Insight Molecular Diagnostics Inc. | — | — | — | SEC filing |
| 2026-04-17 | Buy | Insight Molecular Diagnostics Inc. | 40,114 | $3.57 | $143,251 | SEC filing |
| 2026-04-16 | Buy | Insight Molecular Diagnostics Inc. | — | — | — | SEC filing |
| 2026-04-16 | Buy | Insight Molecular Diagnostics Inc. | 102,057 | $3.45 | $351,658 | SEC filing |
How Form 4 differs from 13F
13F filings are quarterly snapshots, up to 45 days late. Form 4 is transaction-level and lands within two business days — but only covers stocks where the filer reports beneficial ownership above 10%. Pair the two: 13F for the whole portfolio, Form 4 for what the largest holders are doing right now.